leisure time -WSS

leisure time

author：Wikipedia 2025-10-06 07:54:53 - browse：565

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： FDA proposes changes to key medical devices approval pathway

WSS

What to make of Biden’s latest efforts on cancer research

Long Covid needs a new name — and a new frame

EU moves toward latest gene techniques in food production to counter climate change, shortages

Long Covid needs a new name — and a new frame

Food makers to regulators: Ultra

Search warrant issued in 1996 disappearance of Kristin Smart

focus

leisure time

hotspot

Medical leaders decry Supreme Court decision on affirmative action

New weight loss drugs vying to be the next Wegovy or Mounjaro

Medical leaders decry Supreme Court decision on affirmative action

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Trump demands the U.S. pay no more for drugs than other countries … again

IRA could hurt research into orphan drugs for rare diseases

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

explore

Regeneron agrees to White House price limits on anti

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

FDA panel endorses Alnylam’s heart drug — after picking it apart

China dismisses criticism of top diplomat's comments appearing to push for race

2 million sign

PEPFAR is under serious threat — and so is global health

hotspot

focus

entertainment

focus